Viridian Therapeutics, Inc. engages in discovering, developing, and commercializing treatments for serious and rare diseases. It develops IGF-1R therapies to treat thyroid eye disease (TED), including Veligrotrug, a differentiated humanized...
Leadership
Stephen F. Mahoney J.D., MBA
CEO, President & Director
Seth Harmon
Chief Financial Officer
Thomas W. Beetham J.D., MBA
Chief Operating Officer
Jennifer Tousignant J.D.
Chief Legal Officer & Corporate Secretary
Radhika Tripuraneni M.D., M.P.H.
Chief Medical Officer
Eric N. Olson Ph.D.Founder
Co-Founder & Chairman of Scientific Advisory Board
Michael R. Bristow M.D., Ph.D.Founder
Co-Founder & Member of the Scientific Advisory Board
